Ignite Creation Date:
2024-05-05 @ 6:39 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00523380
Status:
COMPLETED
Last Update Posted:
2017-03-01
First Post:
2007-08-30
Brief Title:
Efficacy Study of Recombinant Interleukin-21 in the Treatment of Ovarian Cancer
Sponsor:
Novo Nordisk AS
Organization:
Novo Nordisk AS
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Ovarian Cancer |
| Cancer |
Keywords: